Alvogen, Inc recalls
3 notices naming Alvogen, Inc as the recalling firm, since January 31, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Alvogen, Inc: Levothyroxine Sodium Tablets
Hazard (FDA): Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
FDAMedicines
Alvogen, Inc: Fentanyl Transdermal System CII
Hazard (FDA): Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
FDAMedicines
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Hazard (FDA): There is potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch
FDAMedicines